- Policy
- “Despite vaccine delay, Phase III to complete in 2021"
- by Kim, Jung-Ju Dec 17, 2020 06:11am
- While Genexine’s South Korean-made COVID-19 vaccine trial is expected to get delayed due to change in candidate substance, the health authority reiterated their goal to complete a Phase III clinical trial for a Korean-made vaccine in the latter half of next year is unchanged. Also the official added the global vaccine supply for 1.2 bi
- Policy
- CSOs entrusted to companies are pursuing expenditure reports
- by Kim, Jung-Ju Dec 17, 2020 06:11am
- Amendments to the law will be promoted to mandate expenditure reports related to the provision of economic benefits, etc., submitted by entrusted CSOs to the government. Chun Sook Jung, a member of Democratic Party of Korea representatively proposed a partial amendment to the Pharmaceutical Affairs Act. According to the current law, drug s
- Company
- Pharmaceuticals' dilemma over the possibility of level 3
- by Kim, Jin-Gu Dec 17, 2020 06:11am
- While the government is considering level 3 of social distancing, the pharmaceutical industry is also taking countermeasures. Even if level 3 of social distancing are fully implemented, most of them maintain the flexible working system as they are now. However, internal discussions on the scope of essential manpower are in full swing in that
- Company
- The CEOs of eight multinational companies were replaced
- by Eo, Yun-Ho Dec 16, 2020 02:08pm
- Eight multinational pharmaceutical companies have appointed new CEOs during this year On the 14th, Dailypharm collected the current status of CEOs of major multinational companies in Korea, including 31 Korea Global Pharmaceutical Industry Associations (KRPIA) (currently). As a result, 8 pharmaceutical companies replaced or appointed new
- Company
- Prevymis by MSD is prescribed at Big 5 General Hospitals
- by Eo, Yun-Ho Dec 16, 2020 06:14am
- Prevymis, which is used to prevent cytomegalovirus infection in patients with allogeneic hematopoietic stem cell transplantation, can be prescribed at general hospitals. According to related industries, Prevymis (Letermovir), a prophylactic treatment for cytomegalo virus (CMV) infection in patients with allogeneic hematopoietic stem cell
- Policy
- AZ vaccine is expected to be supplied in Korea the fastest
- by Kim, Jung-Ju Dec 16, 2020 06:14am
- With the spread of COVID-19 in Korea again growing, the quarantine authorities are negotiating on the premise of completing contracts for two products of the overseas COVID-19 vaccine within at least this month. Authorities predicted that the AstraZeneca product would be introduced to Korea the fastest. Jeong Eun-kyeong, head of the Cen
- Opinion
- [Contribution]Which is the first among COVID tx & vaccine?
- by Kang, Shin-Kook Dec 16, 2020 06:14am
- As vaccination has begun in foreign countries and the approval of antibody treatments in Korea is imminent, the need to establish strategies for quarantine is urgently emerging. Will the vaccination aim for population immunity, or will it aim for the effect of preventing severe disease and preventing spread by administering early treatment a
- Product
- “The lower the income, the later the cancer diagnosis”
- by Eo, Yun-Ho Dec 16, 2020 06:13am
- A survey found a clear correlation between the income level and the level of tumor development and metastasis when a patient with cancer is diagnosed. A not-for-profit organization advocating the improvement in inefficiency in cancer treatment environment, ‘All.Can Korea’ kicked off on Dec. 10 and disclosed a survey result on 495 canc
- Company
- AbbVie expands autoimmune disease drug line-up fast
- by Eo, Yun-Ho Dec 15, 2020 06:04am
- AbbVie is quickly lining up next cash cows after Humira. Especially, the company’s speed of new drug reimbursement listing for the South Korean market has impressed the industry. The multinational company only took about six months and five months for an interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) and a Janus kinase (JAK) in
- Policy
- Will special imports be applied for vaccine introduction?
- by Lee, Tak-Sun Dec 15, 2020 06:04am
- Public opinion is growing as the number of COVID-19 confirmed cases is recording the highest every day, and the FDA also urgently approves Pfizer's mRNA-based COVID-19 vaccine following the first vaccination in the UK. Some criticized Korea for failing to preemptively secure a vaccine unlike other advanced countries. It takes some time to
